What's in Y. Michael Shim, MD's pipeline?

Y. Michael Shim, MD has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Y. Michael Shim, MD's portfolio?

Top competitors by shared drug class: Children's Hospital Medical Center, Cincinnati.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/y-michael-shim-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Y. Michael Shim, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Y. Michael Shim, MD pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Hyperpolarized xenon 129	Hyperpolarized xenon 129	marketed	Hyperpolarized gas contrast agent		Pulmonary/Respiratory Imaging

Therapeutic area mix

Pulmonary/Respiratory Imaging · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Children's Hospital Medical Center, Cincinnati · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Y. Michael Shim, MD:

Cite this brief

Drug Landscape (2026). Y. Michael Shim, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/y-michael-shim-md. Accessed 2026-05-17.